NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypotension, Orthostatic, Menkes disease, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, X-linked disease, autonomic nervous system disorder, brain disorder, cardiovascular disorder, central nervous system disorder, disorder of pilosebaceous unit, hereditary disease, hypotensive disorder, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, intellectual disability, metabolic disease, nervous system disorder, orthostatic intolerance, primary dysautonomia, skin disorder, vascular disorder	Recruiting	Phase 1 / Phase 2	2026-10-05		NCT07398508

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Stephen G. Kaler	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Vagelos College of Physicians and Surgeons, Columbia University	New York	United States	1